Generate a tailored SOP for Dr. Stanley Liauw. Improve your application with a focused, well-structured draft.
Dr. Stanley Liauw is a faculty physician at the University of Chicago, serving as the Director of Clinical Operations and the clinical lead for the genitourinary (GU) and gastrointestinal (GI) cancer programs in the Department of Radiation and Cellular Oncology. Over the last decade, he has focused on developing research programs centered on clinical outcomes and clinical trials within these fields. His primary mission involves conducting studies to define current clinical outcomes, develop hypotheses, and test novel regimens aimed at reducing morbidity and mortality associated with radiation therapy for cancer. Dr. Liauw has opened numerous clinical protocols for patients with GU and GI cancers and has initiated phase studies on various treatments, including dose-escalated stereotactic body radiation therapy and combinations of oral hormonal therapy with radiation therapy. His work has contributed to significant advancements in understanding cancer outcomes and improving therapeutic ratios. Additionally, he is actively involved in education, serving as an Associate Editor for the International Journal of Radiation Oncology, Biology, Physics, and as an invited speaker at various national and international forums.
UChicago Medicine • Chicago, IL
Director of Clinical Operations, clinical lead for GU and GI cancer programs.
Department of Philosophy